At the American Diabetes Association 84th Scientific Sessions, researchers presented findings from 4 studies that investigated the impact of various new diabetes technologies on managing the condition.
With the launch of the Dextrometer in 1980, blood glucose self-monitoring became the standard of care for patients with diabetes.1 Since then, advancements in diabetes technologies have increased rapidly, much like the prevalence of the condition itself.
Today, a plethora of diabetes technologies are available to patients with diabetes, with innovations continuously rolling out. Just last year, the FDA cleared the first-ever do-it-yourself automated insulin delivery system.2 Even more recently, the agency approved 2 new OTC continuous glucose monitors (CGMs).3
Underscoring the progress in the industry, 4 abstracts presented at the American Diabetes Association 84th Scientific Sessions, held June 21 to 24 in Orlando, Florida, investigated the impact of various new diabetes technologies on managing the condition.
Click here for more of our coverage from ADA 2024.
READ MORE: Diabetes Resource Center
Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
GLP-1s May Protect Against Cardiovascular Outcomes Regardless of Diabetes Status
October 1st 2024Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.